Prelude Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-138,403
| Closed | -$2.75M | – | 1496 |
|
|
2023
Q1 | $2.75M | Buy |
+138,403
| New | +$2.39M | 0.16% | 147 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | -$4K | – | 2173 |
|
|
2020
Q3 | $4K | Buy |
+100
| New | +$3.23K | ﹤0.01% | 1603 |
|
|
2020
Q2 | – | Sell |
-350
| Closed | -$12K | – | 2331 |
|
|
2020
Q1 | $12K | Sell |
350
-1,447
| -81% | -$61K | ﹤0.01% | 1110 |
|
|
2019
Q4 | $87K | Sell |
1,797
-111
| -6% | -$5.05K | ﹤0.01% | 1160 |
|
|
2019
Q3 | $91K | Buy |
1,908
+1,787
| +1,477% | +$84K | ﹤0.01% | 988 |
|
|
2019
Q2 | $5K | Sell |
121
-498
| -80% | -$19.3K | ﹤0.01% | 1528 |
|
|
2019
Q1 | $24K | Sell |
619
-2,236
| -78% | -$75.8K | ﹤0.01% | 1289 |
|
|
2018
Q4 | $81K | Buy |
2,855
+1,766
| +162% | +$56.1K | 0.01% | 993 |
|
|
2018
Q3 | $43K | Sell |
1,089
-1,589
| -59% | -$58.7K | ﹤0.01% | 1166 |
|
|
2018
Q2 | $87K | Sell |
2,678
-682
| -20% | -$18.8K | 0.01% | 969 |
|
|
2018
Q1 | $74K | Buy |
3,360
+2,207
| +191% | +$53.1K | 0.01% | 951 |
|
|
2017
Q4 | $27K | Sell |
1,153
-7,517
| -87% | -$190K | ﹤0.01% | 1068 |
|
|
2017
Q3 | $244K | Buy |
8,670
+850
| +11% | +$25.9K | 0.02% | 576 |
|
|
2017
Q2 | $252K | Buy |
7,820
+439
| +6% | +$13.4K | 0.02% | 511 |
|
|
2017
Q1 | $209K | Sell |
7,381
-3,245
| -31% | -$86.2K | 0.02% | 549 |
|
|
2016
Q4 | $257K | Buy |
+10,626
| New | +$261K | 0.03% | 487 |
|
|
2015
Q3 | – | Sell |
-12,853
| Closed | -$340K | – | 1880 |
|
|
2015
Q2 | $340K | Hold |
12,853
| – | – | 0.05% | 415 |
|
|
2015
Q1 | $502K | Buy |
+12,853
| New | +$443K | 0.07% | 332 |
|
Other funds holding CSII
Prelude Capital Management's CSII Position: Q2 2023 in Review
Prelude Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 138,403 shares — an estimated $2.75M sold.
Prelude Capital Management first reported a position in CSII in Q1 2015 and held it in 18 quarters. The position peaked at $2.75M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Prelude Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Prelude Capital Management sold 138,403 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $2.75M.
- Prelude Capital Management first reported a position in Cardiovascular Systems, Inc. in Q1 2015 and held it in 18 quarters.
- Prelude Capital Management's Cardiovascular Systems, Inc. position peaked at $2.75M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.